Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1 to 25 of 132

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
3C Patch for treating diabetic foot ulcersMTG66
AMBLor for identifying low-risk non-ulcerated early-stage cutaneous melanomasMIB294
Anifrolumab for treating active autoantibody-positive systemic lupus erythematosus (terminated appraisal)TA793
Antimicrobial prescribing: eravacycline for complicated intra-abdominal infections in adultsES40
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infectionsES39
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Avelumab for maintenance treatment of locally advanced or metastatic urothelial cancer after platinum-based chemotherapyTA788
Belimumab for treating active autoantibody-positive systemic lupus erythematosusTA752
Bladder EpiCheck for detecting bladder cancer recurrenceMIB293
Brain tumours (primary) and brain metastases in over 16sQS203
Cabotegravir with rilpivirine for treating HIV-1TA757
Cemiplimab for treating advanced cutaneous squamous cell carcinomaTA802
Cenobamate for treating focal onset seizures in epilepsyTA753
ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infectionsMTG62
Colorectal cancerNG151
Colorectal cancerQS20
d-Nav insulin management app for type 2 diabetesMIB285
Dapagliflozin for treating chronic kidney diseaseTA775
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Depression in adults: treatment and managementNG222
Diabetes in children and young peopleQS125
Diroximel fumarate for treating relapsing–remitting multiple sclerosisTA794
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779

Results per page

  1. 10
  2. 25
  3. 50
  4. All